• Therapy areas
  • Products
  • Careers
  • About us
  • Patient help
  • Healthcare professionals
  • Media & Investors
  • Contact us

Latest news

{{'Tue, 17 Nov 2026 08:00:00 -0500' | dateFormatUsFilter}}

Novo launches the new Novocare®: Free support program connects people with Wegovy® in addition to home delivery, everyday support, wellness partners and rewards

Read more

{{'Mon, 16 Nov 2026 17:00:00 -0500' | dateFormatUsFilter}}

Novo presents preclinical and human data suggesting a role for amylin and calcitonin receptor activation in preserving bone during weight loss at ObesityWeek®

Read more

{{'Mon, 16 Nov 2026 10:00:00 -0500' | dateFormatUsFilter}}

Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The New England Journal of Medicine

Read more

News archive

Latest on compounded and counterfeit products and other important information about semaglutide.

Visit semaglutide.com

Careers


NOVO USA

800 Scudders Mill Road
Plainsboro, NJ 08536
Tel: 1-609-987-5800

 

Transparency in Employee Health Coverage:

Aetna
United Healthcare

Helpful links

  • Contact us
  • Copyright
  • Report a side effect or product complaint

Follow us

  • Instagram
  • Facebook
  • X (Twitter)
  • TikTok
  • LinkedIn

Other offices

Select location
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Privacy Policy
Consumer Health Data Privacy Notice
Cookie Notice
Cookie Settings
Your Privacy Choices